Joao A. Abrantes

Basel, BS, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

The Advance of In Silico Evidence to Transform Pediatric Drug Development for Rare Diseases.

The Advance of In Silico Evidence to Transform Pediatric Drug Development for Rare Diseases.

Journal: CPT: pharmacometrics & systems pharmacology

Published: October 20, 2025

Physiologically Motivated Sequential Population Modeling of Albumin Trends and Vedolizumab Pharmacokinetics for Pregnancy Dosing Regimen Optimization.

Physiologically Motivated Sequential Population Modeling of Albumin Trends and Vedolizumab Pharmacokinetics for Pregnancy Dosing Regimen Optimization.

Journal: Clinical pharmacology and therapeutics

Published: July 30, 2025

The Basel Modeling and Simulation Seminar: 20 Editions of Fostering Local Exchange in Pharmacometrics.

The Basel Modeling and Simulation Seminar: 20 Editions of Fostering Local Exchange in Pharmacometrics.

Journal: CPT: pharmacometrics & systems pharmacology

Published: June 26, 2025

A semi-mechanistic population pharmacokinetic-pharmacodynamic model to assess downstream drug-target effects on erythropoiesis.

A semi-mechanistic population pharmacokinetic-pharmacodynamic model to assess downstream drug-target effects on erythropoiesis.

Journal: Journal of pharmacokinetics and pharmacodynamics

Published: March 29, 2025

A fully automatic tool for development of population pharmacokinetic models.

A fully automatic tool for development of population pharmacokinetic models.

Journal: CPT: pharmacometrics & systems pharmacology

Published: December 31, 2023

Simulation-based evaluation of the Pharmpy Automatic Model Development tool for population pharmacokinetic modeling in early clinical drug development.

Simulation-based evaluation of the Pharmpy Automatic Model Development tool for population pharmacokinetic modeling in early clinical drug development.

Journal: CPT: pharmacometrics & systems pharmacology

Published: December 22, 2023

Bayesian Forecasting Utilizing Bleeding Information to Support Dose Individualization of Factor VIII.

Bayesian Forecasting Utilizing Bleeding Information to Support Dose Individualization of Factor VIII.

Journal: CPT: pharmacometrics & systems pharmacology

Published: May 06, 2019

Relationship between factor VIII activity, bleeds and individual characteristics in severe hemophilia A patients.

Relationship between factor VIII activity, bleeds and individual characteristics in severe hemophilia A patients.

Journal: Haematologica

Published: February 01, 2019

Handling interoccasion variability in model-based dose individualization using therapeutic drug monitoring data.

Handling interoccasion variability in model-based dose individualization using therapeutic drug monitoring data.

Journal: British journal of clinical pharmacology

Published: July 07, 2018

Elucidation of Factor VIII Activity Pharmacokinetics: A Pooled Population Analysis in Patients With Hemophilia A Treated With Moroctocog Alfa.

Elucidation of Factor VIII Activity Pharmacokinetics: A Pooled Population Analysis in Patients With Hemophilia A Treated With Moroctocog Alfa.

Journal: Clinical pharmacology and therapeutics

Published: December 22, 2016

A Prospective Population Pharmacokinetic Study on Morphine Metabolism in Cancer Patients.

A Prospective Population Pharmacokinetic Study on Morphine Metabolism in Cancer Patients.

Journal: Clinical pharmacokinetics

Published: November 06, 2016

Treatment with subcutaneous and transdermal fentanyl: results from a population pharmacokinetic study in cancer patients.

Treatment with subcutaneous and transdermal fentanyl: results from a population pharmacokinetic study in cancer patients.

Journal: European journal of clinical pharmacology

Published: November 18, 2015

Showing 1-12 of 12

Last Updated: 09/26/2026